Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
17
MPTI Quote, Financials, Valuation and Earnings
Last price:
$49.55
Seasonality move
:
34.56%
Day range:
$48.71 - $52.87
52-week range:
$23.00 - $71.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.80x
P/B ratio:
7.36x
Volume:
79.8K
Avg. volume:
55.4K
1-year change:
52.29%
Market cap:
$134.8M
Revenue:
--
EPS (TTM):
--
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $30M | $26.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -10.97% | |
| Cost of Revenues | -- | -- | -- | $19.7M | $17.4M | |
| Gross Profit | -- | -- | -- | $10.3M | $9.3M | |
| Gross Profit Margin | -- | -- | -- | 34.34% | 34.97% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $7.3M | $7.2M | |
| Other Inc / (Exp) | -- | -- | -- | -$51K | $11K | |
| Operating Expenses | -- | -- | -- | $7.3M | $7.2M | |
| Operating Income | -- | -- | -- | $3M | $2.1M | |
| Net Interest Expenses | -- | -- | -- | $86K | $12K | |
| EBT. Incl. Unusual Items | -- | -- | -- | $2.9M | $2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $583K | $531K | |
| Net Income to Company | -- | -- | -- | $2.3M | $1.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $2.3M | $1.6M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.43 | $0.29 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.43 | $0.29 | |
| Weighted Average Basic Share | -- | -- | -- | $5.4M | $5.4M | |
| Weighted Average Diluted Share | -- | -- | -- | $5.4M | $5.4M | |
| EBITDA | -- | -- | -- | $3.5M | $2.7M | |
| EBIT | -- | -- | -- | $3M | $2.1M | |
| Revenue (Reported) | -- | -- | -- | $30M | $26.7M | |
| Operating Income (Reported) | -- | -- | -- | $3M | $2.1M | |
| Operating Income (Adjusted) | -- | -- | -- | $3M | $2.1M | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $6.4M | $7.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $3.9M | $4.4M | |
| Gross Profit | -- | -- | -- | $2.5M | $2.7M | |
| Gross Profit Margin | -- | -- | -- | 38.43% | 37.54% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $1.7M | $2M | |
| Other Inc / (Exp) | -- | -- | -- | -$7K | -$9K | |
| Operating Expenses | -- | -- | -- | $1.7M | $2M | |
| Operating Income | -- | -- | -- | $793K | $603K | |
| Net Interest Expenses | -- | -- | -- | $3K | $2K | |
| EBT. Incl. Unusual Items | -- | -- | -- | $783K | $592K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $146K | $106K | |
| Net Income to Company | -- | -- | -- | $637K | $486K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $637K | $486K | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.12 | $0.09 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.12 | $0.09 | |
| Weighted Average Basic Share | -- | -- | -- | $5.4M | $5.4M | |
| Weighted Average Diluted Share | -- | -- | -- | $5.4M | $5.4M | |
| EBITDA | -- | -- | -- | $913K | $773K | |
| EBIT | -- | -- | -- | $786K | $594K | |
| Revenue (Reported) | -- | -- | -- | $6.4M | $7.1M | |
| Operating Income (Reported) | -- | -- | -- | $793K | $603K | |
| Operating Income (Adjusted) | -- | -- | -- | $786K | $594K | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $27.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $17.4M | |
| Gross Profit | -- | -- | -- | -- | $10M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $7.5M | |
| Other Inc / (Exp) | -- | -- | -- | $39K | $13K | |
| Operating Expenses | -- | -- | -- | -- | $7.5M | |
| Operating Income | -- | -- | -- | -- | $2.5M | |
| Net Interest Expenses | -- | -- | -- | $6K | $11K | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $2.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $491K | |
| Net Income to Company | -- | -- | -- | -- | $2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $2M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.38 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.38 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | $3.1M | |
| EBIT | -- | -- | -- | -- | $2.5M | |
| Revenue (Reported) | -- | -- | -- | -- | $27.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | $2.5M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $2.5M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $2.5M | $2.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $3.9M | $4M | |
| Inventory | -- | -- | -- | $5.1M | $5.2M | |
| Prepaid Expenses | -- | -- | -- | $233K | $242K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $11.7M | $12.1M | |
| Property Plant And Equipment | -- | -- | -- | $3M | $3.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $16K | $5K | |
| Total Assets | -- | -- | -- | $17.9M | $20M | |
| Accounts Payable | -- | -- | -- | $1.2M | $1.4M | |
| Accrued Expenses | -- | -- | -- | $492K | $403K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $2.8M | $3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $2.9M | $3.2M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | $15M | $16.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $15M | $16.8M | |
| Total Liabilities and Equity | -- | -- | -- | $17.9M | $20M | |
| Cash and Short Terms | -- | -- | -- | $2.5M | $2.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $1.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $4.3M | |
| Inventory | -- | -- | -- | -- | $6.1M | |
| Prepaid Expenses | -- | -- | -- | -- | $213K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $11.8M | |
| Property Plant And Equipment | -- | -- | -- | -- | $3.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $20K | |
| Total Assets | -- | -- | -- | -- | $21.7M | |
| Accounts Payable | -- | -- | -- | -- | $1.6M | |
| Accrued Expenses | -- | -- | -- | -- | $384K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $3.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $3.3M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $18.3M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $21.7M | |
| Cash and Short Terms | -- | -- | -- | -- | $1.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $2.3M | $1.6M | |
| Depreciation & Amoritzation | -- | -- | -- | $489K | $542K | |
| Stock-Based Compensation | -- | -- | -- | $145K | $292K | |
| Change in Accounts Receivable | -- | -- | -- | $215K | -$47K | |
| Change in Inventories | -- | -- | -- | $718K | -$116K | |
| Cash From Operations | -- | -- | -- | $3.9M | $3M | |
| Capital Expenditures | -- | -- | -- | $407K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$407K | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$3.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$588K | -$1.7M | |
| Cash From Financing | -- | -- | -- | -$3.9M | -$1.7M | |
| Beginning Cash (CF) | -- | -- | -- | $2.9M | $2.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$412K | $179K | |
| Ending Cash (CF) | -- | -- | -- | $2.5M | $2.6M | |
| Levered Free Cash Flow | -- | -- | -- | $3.5M | $1.9M | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $637K | $486K | |
| Depreciation & Amoritzation | -- | -- | -- | $127K | $179K | |
| Stock-Based Compensation | -- | -- | -- | $17K | $68K | |
| Change in Accounts Receivable | -- | -- | -- | -$436K | $571K | |
| Change in Inventories | -- | -- | -- | -$230K | -$476K | |
| Cash From Operations | -- | -- | -- | $81K | $1.1M | |
| Capital Expenditures | -- | -- | -- | $345K | $188K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$345K | -$188K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$272K | -$1.4M | |
| Cash From Financing | -- | -- | -- | -$272K | -$1.4M | |
| Beginning Cash (CF) | -- | -- | -- | $2.5M | $1.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$536K | -$457K | |
| Ending Cash (CF) | -- | -- | -- | $2M | $1.1M | |
| Levered Free Cash Flow | -- | -- | -- | -$264K | $936K | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $591K | |
| Stock-Based Compensation | -- | -- | -- | $89K | $376K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$340K | |
| Change in Inventories | -- | -- | -- | -- | -$1.2M | |
| Cash From Operations | -- | -- | -- | -- | $1.9M | |
| Capital Expenditures | -- | -- | -- | $400K | $795K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$795K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$3.1M | |
| Cash From Financing | -- | -- | -- | -- | -$3.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $1.1M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get MPTI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MPTI
Sector
P/E ratio
--
25.26x
PEG ratio
--
0.06x
P/B ratio
7.36x
2.37x
Price / LTM sales
9.80x
1.88x
Growth Metrics
MPTI
Sector
Revenue growth
--
4.2%
Earnings growth
--
9.52%
Revenue (5-year growth)
--
6.47%
Earnings forecast
--
$0.12
Profitability
MPTI
Sector
Profitability FY 2024
--
$100.9M
Return on invested capital
--
1.74%
Return on assets
--
0.52%
Return on equity
--
2.9%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
26
Estimated Next Earnings Date
Feb
12
Balance Sheet
MPTI
Sector
Total cash
--
$58.4M
Short term investments
--
$27.5M
Total assets
--
$285.5M
Long term debt
--
$4.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
